- New Home Sales grew 0.4% in October.
- New Home Sales growth in September received a hefty downgrade to 7.1% from 14%.
- Thus, the number of sales over the past 12 months came in at just 745K, versus last month's estimate of 800K prior to revisions.
Following a 7.1% (downwardly revised from 14.0%) surge in sales in September, New Home Sales in the US rose by a modest 0.4% in October, data published by the US Commerce Department showed on Wednesday.
Given the hefty downwards revision to the September figure, instead of rising to 800K, the number of New Home Sales over the past 12 months rose to just 745K from 742K in September. Note that last month's New Home Sales over the past 12 months figure was revised lower from 800K.
Despite New Home Sales over the past 12 months running at a much slower pace than thought prior to Wednesday's data release, FX markets have not seen any reaction to the data.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.